
A large-scale TriNetX database analysis found no statistically significant difference in the incidence of vulvar atrophy or hypertrophy between non-diabetic women using GLP-1RAs and those who were not.

Jessica Yih, MD, Board-certified urologist, field of sexual medicine, University of California, Irvine.